Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H26BrNOS |
| Molecular Weight | 408.396 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)[C@]1(CC[C@@](O)(CCC2=CC=CS2)CC1)C3=CC=C(Br)C=C3
InChI
InChIKey=XRDNIYBVNZLPJE-MXVIHJGJSA-N
InChI=1S/C20H26BrNOS/c1-22(2)20(16-5-7-17(21)8-6-16)13-11-19(23,12-14-20)10-9-18-4-3-15-24-18/h3-8,15,23H,9-14H2,1-2H3/t19-,20-
| Molecular Formula | C20H26BrNOS |
| Molecular Weight | 408.396 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:59:14 GMT 2023
by
admin
on
Sat Dec 16 17:59:14 GMT 2023
|
| Record UNII |
D343S4VX5G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
11058633
Created by
admin on Sat Dec 16 17:59:15 GMT 2023 , Edited by admin on Sat Dec 16 17:59:15 GMT 2023
|
PRIMARY | |||
|
D343S4VX5G
Created by
admin on Sat Dec 16 17:59:15 GMT 2023 , Edited by admin on Sat Dec 16 17:59:15 GMT 2023
|
PRIMARY | |||
|
C-8813
Created by
admin on Sat Dec 16 17:59:15 GMT 2023 , Edited by admin on Sat Dec 16 17:59:15 GMT 2023
|
PRIMARY | |||
|
616898-54-5
Created by
admin on Sat Dec 16 17:59:15 GMT 2023 , Edited by admin on Sat Dec 16 17:59:15 GMT 2023
|
PRIMARY | |||
|
DTXSID90101841
Created by
admin on Sat Dec 16 17:59:15 GMT 2023 , Edited by admin on Sat Dec 16 17:59:15 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
In the MVD, C8813 could inhibit the electrically induced contraction, but weaker than in the GPI. Moreover, this inhibitory effect could antagonized by the δ-opioid receptor antagonist ICI174864. These results indicated C8813 also acted on δ-opioid receptor but less potent than on μ-opioid receptor.
|
||
|
|
OFF TARGET->NON-INHIBITOR |
|
||
|
TARGET -> AGONIST |
In mouse hot plate test, the antinociceptive ED50 of C8813 was 11.5 μg/kg, being 591 times and 3.4 times more potent than morphine and fentanyl respectively.
Ki
|
